glutamic acid has been researched along with piperidine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burney, MW; Case, BL; Ennis, MD; Girard, TJ; Hall, KA; Hiebsch, RR; Huff, RM; Lachance, RM; Mischke, DA; Parlow, JJ; Rapp, SR; Woerndle, RS | 1 |
| Arce, MP; Conde, S; García, AG; González-Muñoz, GC; López, B; López, MG; Pérez, C; Rodríguez-Franco, MI; Villarroya, M | 1 |
| Gill, MB; Ikoma, M; Oikawa, M; Sakai, R; Sasaki, M; Shimamoto, K; Swanson, GT | 1 |
3 other study(ies) available for glutamic acid and piperidine
| Article | Year |
|---|---|
Piperazinyl-glutamate-pyrimidines as potent P2Y12 antagonists for inhibition of platelet aggregation.
Topics: Animals; Fibrinolytic Agents; Glutamic Acid; Humans; Male; Piperidines; Platelet Aggregation; Purinergic P2 Receptor Antagonists; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Structure-Activity Relationship | 2009 |
Neuroprotective and cholinergic properties of multifunctional glutamic acid derivatives for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Blood-Brain Barrier; Catalytic Domain; Cattle; Cell Death; Cell Line, Tumor; Cell Survival; Cholinergic Agents; Cholinesterase Inhibitors; Esters; Glutamic Acid; Humans; Hydrophobic and Hydrophilic Interactions; Neuroprotective Agents; Permeability; Piperidines; Protein Binding | 2009 |
Improved synthesis and in vitro/in vivo activities of natural product-inspired, artificial glutamate analogs.
Topics: Animals; Biological Products; Electrophysiological Phenomena; Glutamic Acid; Heterocyclic Compounds; Mice; Neurons; Piperidines; Pyrrolidinones; Receptors, AMPA | 2010 |